Thomas Hankemeier is full professor of Analytical BioSciences at the LACDR, Leiden University, since 2004. He leads as principal investigator the Analytical BioSciences and Metabolomics group, and he is the chair of the new Division of Systems Biomedicine and Pharmacology. His research is aiming at innovative analytical tools for metabolomics-driven systems biology in personalised health strategies.
Junaid A, Tang H, van Reeuwijk A, Abouleila Y, Wuelfroth P, van Duinen V, Stam W, van Zonneveld AJ, Hankemeier T, and Mashagh A.
iScience. 2020 Jan 24; 23(1): 100765
Oedita A, Duivelshofa B, Lindenburg PW, Hankemeier T.
Journal of Chromatography A, Volume 1610, 11 January 2020, 460570
hankemeijer@lacdr.leidenuniv.nl
Leiden University
Gorlaeus Building
Einsteinweg 55
2333 CC Leiden
Room number GW4.07
We know far less about the exposome than we do about the human genome. So far, we only understand about half of the disease burden for which we know the environment plays a role. If we want to prevent people from becoming ill, then we need to understand the other half too. We therefore want to systematically analyse the exposome for the first time. We will start with research into the causes of cardiovascular disease and type 2 diabetes. The techniques and insights from this research will also be applicable to other chronic conditions.
Read More
